SSE plc Chief Executive Succession Plan
SSE plc Interim Results for Six Months Ended 30th September 2024
AstraZeneca plc to Invest $3.5bn in the United States
AstraZeneca plc Announces KOMET Phase III Trial Met Primary Endpoint
AstraZeneca plc 9 Month and Third Quarter 2024 Results
Concurrent Technologies plc Contract with Leading Defence Provider in Asia
Ocean Wilsons Quarterly Update – Q3 2024
